Biotech | February 18, 2022
USFDA clears Kairos Pharma’s IND to treat prostrate cancer
Phase 2 clinical trial to begin in 2022 with participation by Cedars Sinai Medical Center, University of Utah, and City of Hope
Phase 2 clinical trial to begin in 2022 with participation by Cedars Sinai Medical Center, University of Utah, and City of Hope
The insights collected by the app will support the pharmaceutical industry’s efforts to further improve patients’ lives by providing actionable data on patients’ individual experiences
ArisGlobal's industry-leading regulatory software chosen by top pharmaceutical company for IDMP preparation and global readiness
AptarGroup acquired Voluntis and 80% of Weihai Hengyu Medical Products in 2021.
The commissioned facility has a capacity of 7,000 TPA to produce various Esters (Mono Methyl Acetoacetamide, Methyl Acetoacetate, Ethyl Acetoacetate, and Ter-Butyl Acetoacetate)
The device will facilitate the treatment of cerebral vasospasm following hemorrhagic stroke
Launches a host of innovative products & solutions across the entire flexible packaging value chain in October - December 2021
The service has already been initiated in Maharashtra but being net-based it is easily available for patients all across the country
AstraZeneca will hold the registration and manufacture Pulmicort Respules, while Glenmark will commercialize the product in Columbia
It will showcase the company’s latest technologies in robotics, digital health and orthopaedic implants
Subscribe To Our Newsletter & Stay Updated
